Fluorine in PDB 7dfg: Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir

All present enzymatic activity of Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir:
2.7.7.48;

The structure of Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir also contains other interesting chemical elements:

Magnesium	(Mg)	4 atoms
Zinc	(Zn)	2 atoms

The binding sites of Fluorine atom in the Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir (pdb code 7dfg). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir, PDB code: 7dfg:

Fluorine binding site 1 out of 1 in the Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure of Covid-19 Rna-Dependent Rna Polymerase Bound to Favipiravir within 5.0Å range: probe atom residue distance (Å) B Occ P:F1201 b:0.5 occ:1.00 FAI P:1RP1201 0.0 0.5 1.0 CAP P:1RP1201 1.3 0.5 1.0 NAL P:1RP1201 2.3 0.5 1.0 CAJ P:1RP1201 2.4 0.5 1.0 OAG P:1RP1201 3.3 0.5 1.0 CAR P:1RP1201 3.5 0.5 1.0 C5 P:U20 3.5 40.7 1.0 NAW P:1RP1201 3.6 0.5 1.0 C6 P:U20 3.7 40.7 1.0 O5' P:1RP1201 3.9 0.5 1.0 C4 P:U20 3.9 40.7 1.0 CAQ P:1RP1201 4.0 0.5 1.0 O A:HOH1104 4.2 57.3 1.0 N1 P:U20 4.2 40.7 1.0 PAX P:1RP1201 4.3 0.5 1.0 N3 P:U20 4.4 40.7 1.0 C2' P:U20 4.4 40.7 1.0 C3' P:U20 4.4 40.7 1.0 O4 P:U20 4.5 40.7 1.0 O P:HOH1301 4.5 47.3 1.0 C2 P:U20 4.5 40.7 1.0 NZ A:LYS545 4.6 46.0 1.0 CAO P:1RP1201 4.7 0.5 1.0 NAA P:1RP1201 4.8 0.5 1.0 O3' P:U20 4.8 40.7 1.0 C1' P:1RP1201 4.8 0.5 1.0 O4' P:1RP1201 4.9 0.5 1.0 C1' P:U20 5.0 40.7 1.0

W.Yin, X.Luan, Z.Li, Y.Xie, Z.Zhou, J.Liu, M.Gao, X.Wang, F.Zhou, Q.Wang, Q.Wang, D.Shen, Y.Zhang, G.Tian, H.Aisa, D.Wei, Y.Jiang, G.Xiao, H.Jiang, L.Zhang, X.Yu, J.Shen, S.Zhang, H.Xu. Structural Basis For Repurpose and Design of Nucleotide Drugs For Treating Covid-19 To Be Published.